Anthropic says Claude found a CRISPR-like enzyme system
The company says Claude agents searched DNA data, surfaced a new candidate system, and handed it to human scientists for lab validation.
Anthropic says Claude agents found a previously uncharacterized enzyme system with CRISPR-like repeats, the first public result from the company’s new life-sciences lab.
The company says scientists gave Claude a broad prompt to search DNA sequence data for unusual reverse transcriptases. Roughly 950 Claude agents then scanned protein clusters, narrowed thousands of candidate systems, and surfaced what Anthropic now calls array-associated reverse transcriptases, or ART. Human scientists reviewed the reports and ran the lab work; Anthropic says the system’s function is still unknown.
The practical point is not that Claude has delivered a ready gene-editing tool. It has not. The important signal is that a frontier model was used as an autonomous research scout across a huge biological search space, then handed off to humans for validation.
That makes Anthropic’s wet lab more than a corporate curiosity. The company is trying to show that AI agents can generate testable biology hypotheses, while also operating in one of the highest-risk areas for AI safety policy.
Anthropic
